SCHEMBL17816180

SCHEMBL17816180

CC[C@]1(C(=O)O)C[C@@H](Sc2cc(C(=O)Nc3ccc(F)c(Cl)c3)ccc2I)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.42
MAOB P27338 3/20 0.41
MAOA P21397 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
KCNE1 P15382 1/20 0.40
KCNQ1 P51787 1/20 0.40
CCR2 P41597 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816170 1.00 NPC1 (0.46) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17784057 0.93 NPC1 (0.49) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17792186 0.93 NPC1 (0.49) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17784055 0.93 NPC1 (0.49) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17795673 0.93 NPC1 (0.49) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17792136 0.86 NPC1 (0.47) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17792135 0.84 NPC1 (0.45) NPC1RAB9ACHRM1TSHRMAOB
SCHEMBL17816163 0.83 NPC1 (0.44) NPC1RAB9ACHRM1MAOBMAOA
SCHEMBL17816177 0.83 NPC1 (0.47) NPC1RAB9ACHRM1MAOBMAOA
SCHEMBL17816165 0.82 NPC1 (0.47) NPC1RAB9ACHRM1MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed